Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ambrisentan for use in the treatment of acute renal failure

Ambrisentan for use in the treatment of acute renal failure

US Patent 11642307 · Granted May 9, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of portal hypertension and cirrhosis2024
Ambrisentan for use in the treatment of acute renal failure2020